ArticleScientific reports2025
Knowledge of pharmacy students about autism spectrum disorder in Brazil.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pharmacy students' and pharmacists' limited knowledge about Autism Spectrum Disorder (ASD) can have negative impacts on health care for these individuals. In Brazil, no studies have assessed ASD knowledge among Pharmacy students. This study aims to assess the ASD knowledge among Pharmacy students in Brazil. A cross-sectional survey was conducted with Pharmacy students in Brazil from September 2021 to August 2022. Participants answered online questions about sociodemographic data, contact with people with ASD, and the Brazilian validated version of the Autism Stigma Knowledge - Questionnaire (ASK-Q Brazil), a 49-item questionnaire that assesses ASD knowledge and stigma. Descriptive statistics and the T test were used. This study was approved by the Research Ethics Committee (Opinion No. 4,464,411). Of the 397 students who participated, most demonstrated adequate knowledge and did not endorse ASD stigma: etiology (99.0%), diagnosis/symptoms (97.0%), treatment (98.7%), and lack of stigma endorsement (100.0%). Those who had a family member with ASD had the highest correct answers in the treatment (p = 0.001; d = 0.45) and diagnosis/symptoms (p = 0.015; d = 0.24) domains. This study showed that almost all students have adequate knowledge about ASD and do not endorse stigma. The results can contribute to the definition of strategies to improve the qualification of future pharmaceutical professionals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.